Ronald T. Piervincenzi, Ph.D.
Board Director | Chief Executive Officer, United States Pharmacopeia (USP)
Ron began his tenure as Chief Executive Officer of USP in February 2014. He provides strategic leadership to USP’s global staff of over 1,300 across sites in the U.S. (Rockville, MD; Frederick, MD; Washington D.C.), India, Brazil, China, Ghana, and Switzerland, and global public health field offices including Bangladesh, Ethiopia, Ghana, Indonesia, Kenya, Nepal, Nigeria, Pakistan, and Uzbekistan. USP has been a leader in quality since its founding in 1820, and that has continued during Ron’s tenure as the organization continues to incorporate quality across the healthcare spectrum. He has helped USP modernize its operations and launch innovative science, including in the areas of digital medicine, cutting-edge manufacturing technologies, and advanced biologics. Under Ron’s leadership, USP has built a growing suite of “capability building” service offerings, including quality manufacturing consulting, donor-funded work, and education.
Ron brings more than 20 years of industry experience across pharmaceutical sciences, research, and business strategy. Before joining USP, he served as Vice President of Development Sciences with Biogen, where he designed and launched Biogen’s value-based medicine group focusing on applying tools and technologies of personalized medicine in the treatment and management of multiple sclerosis. Ron is a former partner and leader in McKinsey & Company’s global pharmaceutical and medical products practice for over 12 years, helping launch McKinsey’s global drug safety, medical and regulatory service line. With McKinsey, Ron led the global research and information analytics team, managing staff in New Jersey, London, Brussels, and India.